Cell Therapeutics (CTIC +32%) rockets higher this morning after announcing the initiation of its...

|About: CTI BioPharma Corp. (CTIC)|By:, SA News Editor

Cell Therapeutics (CTIC +32%) rockets higher this morning after announcing the initiation of its commercial launch of Pixuvri in the European Union. Pixuvri is a drug for the treatment of aggressive non-Hodgkin Lymphoma.